Synacthen 0.25 mg/ 1 mL ampoule Malta - English - Medicines Authority

synacthen 0.25 mg/ 1 ml ampoule

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - tetracosactide acetate - solution for injection/infusion - tetracosactide acetate 0.25 mg/ml - pituitary and hypothalamic hormones and analogues

SYNACTHEN 250 mcg/ml Microgram/ML Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

synacthen 250 mcg/ml microgram/ml solution for injection

sigma-tau industrie farmaceutiche riunite s.p.a. - tetracosactide acetate - solution for injection - 250 mcg/ml microgram/ml - acth

Synacthen New Zealand - English - Medsafe (Medicines Safety Authority)

synacthen

clinect nz pty limited - tetracosactide 0.25 mg/ml equivalent to tetracosactide hexaacetate 0.28 mg/ml - solution for injection - 0.25 mg/ml - active: tetracosactide 0.25 mg/ml equivalent to tetracosactide hexaacetate 0.28 mg/ml excipient: acetic acid sodium acetate trihydrate sodium chloride water for injection - for the investigation of adrenocortical insufficiency

Synacthen Depot New Zealand - English - Medsafe (Medicines Safety Authority)

synacthen depot

clinect nz pty limited - tetracosactide 1 mg/ml equivalent to tetracosactide hexaacetate 1.12 mg/ml - injection (depot) - 1 mg/ml - active: tetracosactide 1 mg/ml equivalent to tetracosactide hexaacetate 1.12 mg/ml excipient: benzyl alcohol dibasic sodium phosphate dodecahydrate hydrochloric acid sodium chloride sodium hydroxide water for injection zinc chloride - diagnostic use for the investigation of adrenocortical insufficiency: a 5-hour test canbe peerformed using synacthen depot when the 30-minute test with synacthen i.m./i.v. gives inconclusive results, or if the aim is to determine the functional reserve of the adrenal cortex.

Cosacthen 0.25 mg/ml solution for injection for dogs Ireland - English - HPRA (Health Products Regulatory Authority)

cosacthen 0.25 mg/ml solution for injection for dogs

dechra regulatory b.v. - tetracosactide hexaacetate - solution for injection - 0.25 milligram(s)/millilitre - tetracosactide

TETRACOSACTIDE ACETATE- ACTH 1-24 powder United States - English - NLM (National Library of Medicine)

tetracosactide acetate- acth 1-24 powder

bluebay shandong co.,ltd - cosyntropin (unii: 72yy86ea29) (cosyntropin - unii:72yy86ea29) -

Synacthen Depot 1mg/1mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

synacthen depot 1mg/1ml injection ampoule

atnahs pharma australia pty ltd - tetracosactide, quantity: 1 mg/ml - injection, modified release - excipient ingredients: hydrochloric acid; water for injections; dibasic sodium phosphate dihydrate; sodium chloride; zinc chloride; sodium hydroxide; benzyl alcohol - neurological diseases: acute exacerbations in patients suffering from multiple sclerosis. hypsarrhythmia, and or infantile spasms

Cosacthen 0,25 mg/ml inj. sol. i.v./i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cosacthen 0,25 mg/ml inj. sol. i.v./i.m. vial

dechra regulatory b.v. - tetracosactide hexaacetate 0,28 mg/ml - eq. tetracosactide 0,25 mg/ml - solution for injection - 0,25 mg/ml - tetracosactide hexaacetate 0.28 mg/ml - tetracosactide - dog

SYNACTHEN Solution for Injection 250 mcg/ml Microgram/ML Ireland - English - HPRA (Health Products Regulatory Authority)

synacthen solution for injection 250 mcg/ml microgram/ml

defiante farmaceutica, s.a. - tetracosactide acetate - solution for injection - 250 mcg/ml microgram/ml

SYNACTHEN DEPOT SUSPENSION Canada - English - Health Canada

synacthen depot suspension

atnahs pharma uk limited - tetracosactide (tetracosactide zinc hydroxide) - suspension - 1mg - tetracosactide (tetracosactide zinc hydroxide) 1mg - adrenocortical insufficiency